[1]
L. Kurbatov, S. . Radko, S. Khmeleva, O. Timoshenko, and A. Lisitsa, “ Evaluation of the Collateral Activity of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer”, BIOMED CHEM RM, vol. 5, no. 2, p. e00169, Jun. 2022.